Literature DB >> 31452211

Patient-reported effect in patients receiving implant or tooth-supported fixed prosthesis.

Esben B Øzhayat1, Klaus Gotfredsen1.   

Abstract

OBJECTIVES: To compare the patient-reported effect of treatment with implant-supported fixed prosthesis (ISFP) and fixed dental prosthesis (FDP) in patients with a small number of tooth losses to replace.
METHODS: From a population of 155 patients receiving either ISFP or FDP, 68 patients were matched in pairs based on gender, number of teeth replaced, zone of replacement, age and number of remaining teeth. The patient-reported effect was prospectively obtained by measuring change in the short-form oral health impact (OHIP-14) from before to one month after treatment. Effect size (ES), standardised response mean (SRM) and a minimal important difference of two units were applied to estimate the magnitude of the change.
RESULTS: Both the ISFP and FDP groups decreased significantly in OHIP-14 after treatment (P < .01). The change was not significantly different between the ISFP and FDP groups. The magnitude of the change was for both treatments moderate and slightly higher in the ISFP group (ES = 0.52 and SRM = 0.58) than in the FDP group (ES = 0.48 and SRM = 0.47). Applying the minimal important difference showed that 23 participants in the ISFP group and 21 in the FDP group had good effect.
CONCLUSIONS: The patient-reported effect of treatment with ISFP or FDP was similar, clinically meaningful and of moderate magnitude in patients with a small number tooth losses to replace.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  clinical decision-making; patient comfort; patient-reported outcome measures; prosthesis and implants; quality of life

Year:  2019        PMID: 31452211     DOI: 10.1111/joor.12880

Source DB:  PubMed          Journal:  J Oral Rehabil        ISSN: 0305-182X            Impact factor:   3.837


  1 in total

1.  A Danish version of the oral health impact profile-14 (OHIP-14): translation and cross-cultural adaptation.

Authors:  Arwa Gera; Paolo M Cattaneo; Marie A Cornelis
Journal:  BMC Oral Health       Date:  2020-09-10       Impact factor: 2.757

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.